Longitudinal evaluation of prostate-specific antigen levels in a case-control study

F De Biasi1, D Londero, S Praturlon

  • 1Institutes of Nuclear Medicine, General Hospital, Udine, Italy.

European Urology
|January 1, 1996
PubMed
Summary

The rate of change in prostate-specific antigen (PSA) levels, known as delta PSA, is a more effective indicator for detecting prostate cancer in asymptomatic men than PSA levels alone. This finding aids in early diagnosis and discrimination between benign and malignant prostatic conditions.